BMJ 1994;308:158 (15 January)

News

British company fined for falling foul of Cancer Act

O Dyer 

A company in Britain that sells herbal medicines was convicted last week under the Cancer Act 1939 of making illegal claims about one of its products. Eladon Ltd, which operates from Bangor, north Wales, was fined pounds sterling 500 and ordered to pay pounds sterling 3500 costs after being found guilty by magistrates in Whitminster of contravening the act in its promotional material.

Eladon's product, Elagen, is an extract of Siberian eleutherococcus, a root widely used by doctors in Russia, where it is credited with curing a wide range of ailments. The claims about its efficacy were sent to potential customers who had first made inquiries to the company. Eladon was reported to Gloucestershire County Council's trading standards department by Dr Charles Shepherd of Stroud, Gloucestershire, a medical adviser to the ME Association (for patients with myalgic encephalomyelitis) after he was approached to write a review of Elagen. Dr . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Relevant Article

Shark cartilage in the water: Effective legislation is already in place but is not being properly used
Charles B Shepherd
BMJ 2006 333: 1222. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Shepherd, C. B (2006). Shark cartilage in the water: Effective legislation is already in place but is not being properly used. BMJ 333: 1222-1222 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ